BioInvent International AB Financial Flexibility Index
BioInvent International AB financial flexibility index. BioInvent International AB (BINV) has a Financial Flexibility Index of 0.64x as of June 2025. Free cash flow of Skr68.16 Million (operating CF Skr66.78 Million minus capex Skr1.38 Million) represents 1% of total liabilities (Skr105.93 Million). Explore BINV capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of BioInvent International AB (2002–2024)
Financial flexibility index of BioInvent International AB from 2002 to 2024. Historical Financial Flexibility Index trend for BioInvent International AB across 23 annual periods. Check cash flow reinvestment rate of BioInvent International AB to assess the company's total reinvestment commitment from operating cash flow.
BioInvent International AB Financial Flexibility Index by Year (2002–2024)
BioInvent International AB financial flexibility index by year from 2002 to 2024. Year-by-year free cash flow to debt coverage for BioInvent International AB. For the full cash flow conversion analysis, see BioInvent International AB cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.58x | Skr-370.44 Million | Skr-380.47 Million | Skr103.42 Million | ▲ +1.3% |
| 2023 | -3.63x | Skr-328.39 Million | Skr-341.69 Million | Skr90.45 Million | ▼ -1235.1% |
| 2022 | -0.27x | Skr-28.85 Million | Skr-41.23 Million | Skr106.09 Million | ▲ +90.6% |
| 2021 | -2.90x | Skr-232.58 Million | Skr-245.84 Million | Skr80.32 Million | ▼ -206.2% |
| 2020 | -0.95x | Skr-55.92 Million | Skr-62.62 Million | Skr59.14 Million | ▲ +55.9% |
| 2019 | -2.15x | Skr-121.59 Million | Skr-125.43 Million | Skr56.67 Million | ▲ +48.9% |
| 2018 | -4.20x | Skr-137.55 Million | Skr-141.39 Million | Skr32.78 Million | ▼ -181.3% |
| 2017 | -1.49x | Skr-59.40 Million | Skr-75.88 Million | Skr39.82 Million | ▼ -2.5% |
| 2016 | -1.45x | Skr-66.73 Million | Skr-72.05 Million | Skr45.86 Million | ▲ +49.4% |
| 2015 | -2.88x | Skr-71.90 Million | Skr-72.57 Million | Skr24.99 Million | ▲ +17.5% |
| 2014 | -3.49x | Skr-75.61 Million | Skr-76.03 Million | Skr21.68 Million | ▼ -107.1% |
| 2013 | -1.68x | Skr-54.60 Million | Skr-54.65 Million | Skr32.43 Million | ▲ +31.9% |
| 2012 | -2.47x | Skr-170.32 Million | Skr-170.38 Million | Skr68.92 Million | ▼ -231.6% |
| 2011 | -0.75x | Skr-50.54 Million | Skr-55.45 Million | Skr67.81 Million | ▲ +57.9% |
| 2010 | -1.77x | Skr-113.07 Million | Skr-117.70 Million | Skr63.84 Million | ▲ +0.6% |
| 2009 | -1.78x | Skr-125.85 Million | Skr-127.14 Million | Skr70.61 Million | ▼ -299.2% |
| 2008 | 0.89x | Skr57.37 Million | Skr43.73 Million | Skr64.13 Million | ▲ +207.7% |
| 2007 | 0.29x | Skr16.54 Million | Skr12.63 Million | Skr56.88 Million | ▲ +112.0% |
| 2006 | -2.42x | Skr-92.27 Million | Skr-101.23 Million | Skr38.18 Million | ▼ -39.3% |
| 2005 | -1.73x | Skr-82.11 Million | Skr-105.48 Million | Skr47.34 Million | ▲ +46.4% |
| 2004 | -3.23x | Skr-83.18 Million | Skr-88.74 Million | Skr25.73 Million | ▼ -116.8% |
| 2003 | -1.49x | Skr-57.02 Million | Skr-66.25 Million | Skr38.23 Million | ▼ -399.9% |
| 2002 | 0.50x | Skr25.94 Million | Skr-10.57 Million | Skr52.16 Million | — |